Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1989 1
2002 1
2003 1
2005 2
2006 3
2008 3
2009 5
2010 9
2011 7
2012 5
2013 8
2014 15
2015 11
2016 8
2017 20
2018 29
2019 37
2020 47
2021 56
2022 69
2023 96
2024 141
2025 127
2026 73

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

645 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis.
Di Molfetta S, Di Gioia L, Caruso I, Cignarelli A, Green SC, Natale P, Strippoli GFM, Sorice GP, Perrini S, Natalicchio A, Laviola L, Giorgino F. Di Molfetta S, et al. Diabetes Metab Res Rev. 2024 Sep;40(6):e3842. doi: 10.1002/dmrr.3842. Diabetes Metab Res Rev. 2024. PMID: 39298688
AIMS: To compare the efficacy and safety of different hybrid closed loop (HCL) systems in people with diabetes through a network meta-analysis. METHODS: We searched MEDLINE, EMBASE, CENTRAL and PubMed for randomised clinical trials (RCTs) enrolling children, adolesc …
AIMS: To compare the efficacy and safety of different hybrid closed loop (HCL) systems in people with diabetes through a netwo …
Automated closed-loop insulin delivery for the management of type 1 diabetes during pregnancy: the AiDAPT RCT.
Lee TTM, Collett C, Bergford S, Hartnell S, Scott EM, Lindsay RS, Hunt KF, McCance DR, Barnard-Kelly K, Rankin D, Lawton J, Reynolds RM, Flanagan E, Hammond M, Shepstone L, Wilinska ME, Sibayan J, Kollman C, Beck R, Hovorka R, Murphy HR. Lee TTM, et al. Southampton (UK): National Institute for Health and Care Research; 2024 Apr. Southampton (UK): National Institute for Health and Care Research; 2024 Apr. PMID: 38718153 Free Books & Documents. Review.
Women were randomly assigned to either a hybrid closed-loop system or standard insulin delivery (insulin pump or multiple daily injections) with continuous glucose monitoring. ...Mothers in the closed-loop group had less weight gai …
Women were randomly assigned to either a hybrid closed-loop system or standard insulin delivery (insulin …
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice.
Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, Kovatchev BP, Messer LH, Parkin CG, Ambler-Osborn L, Amiel SA, Bally L, Beck RW, Biester S, Biester T, Blanchette JE, Bosi E, Boughton CK, Breton MD, Brown SA, Buckingham BA, Cai A, Carlson AL, Castle JR, Choudhary P, Close KL, Cobelli C, Criego AB, Davis E, de Beaufort C, de Bock MI, DeSalvo DJ, DeVries JH, Dovc K, Doyle FJ, Ekhlaspour L, Shvalb NF, Forlenza GP, Gallen G, Garg SK, Gershenoff DC, Gonder-Frederick LA, Haidar A, Hartnell S, Heinemann L, Heller S, Hirsch IB, Hood KK, Isaacs D, Klonoff DC, Kordonouri O, Kowalski A, Laffel L, Lawton J, Lal RA, Leelarathna L, Maahs DM, Murphy HR, Nørgaard K, O'Neal D, Oser S, Oser T, Renard E, Riddell MC, Rodbard D, Russell SJ, Schatz DA, Shah VN, Sherr JL, Simonson GD, Wadwa RP, Ward C, Weinzimer SA, Wilmot EG, Battelino T. Phillip M, et al. Endocr Rev. 2023 Mar 4;44(2):254-280. doi: 10.1210/endrev/bnac022. Endocr Rev. 2023. PMID: 36066457 Free PMC article.
During the past 6 years, we have seen tremendous advances in automated insulin delivery (AID) technologies. Numerous randomized controlled trials and real-world studies have shown that the use of AID systems is safe and effective in helping PwD achieve their …
During the past 6 years, we have seen tremendous advances in automated insulin delivery (AID) technologies. Numerous ra …
Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.
Lee TTM, Collett C, Bergford S, Hartnell S, Scott EM, Lindsay RS, Hunt KF, McCance DR, Barnard-Kelly K, Rankin D, Lawton J, Reynolds RM, Flanagan E, Hammond M, Shepstone L, Wilinska ME, Sibayan J, Kollman C, Beck R, Hovorka R, Murphy HR; AiDAPT Collaborative Group. Lee TTM, et al. N Engl J Med. 2023 Oct 26;389(17):1566-1578. doi: 10.1056/NEJMoa2303911. Epub 2023 Oct 5. N Engl J Med. 2023. PMID: 37796241 Clinical Trial.
BACKGROUND: Hybrid closed-loop insulin therapy has shown promise for management of type 1 diabetes during pregnancy; however, its efficacy is unclear. ...No unanticipated safety problems associated with the use of closed-loop therapy during preg …
BACKGROUND: Hybrid closed-loop insulin therapy has shown promise for management of type 1 diabetes during pregnancy; ho …
Automated Insulin Delivery in Older Adults with Type 1 Diabetes.
Kudva YC, Henderson RJ, Kanapka LG, Weinstock RS, Rickels MR, Pratley RE, Chaytor N, Janess K, Desjardins D, Pattan V, Peleckis AJ, Casu A, Rizvi SR, Bzdick S, Whitaker KJ, Jo Kamimoto JL, Miller K, Kollman C, Beck RW. Kudva YC, et al. NEJM Evid. 2025 Jan;4(1):EVIDoa2400200. doi: 10.1056/EVIDoa2400200. Epub 2024 Dec 23. NEJM Evid. 2025. PMID: 39714936 Free PMC article. Clinical Trial.
Participants completed three 12-week periods of using hybrid closed loop, predictive low-glucose suspend, and sensor-augmented pump insulin delivery in a randomized order. ...CONCLUSIONS: In older adults with type 1 diabetes, automated insuli …
Participants completed three 12-week periods of using hybrid closed loop, predictive low-glucose suspend, and sensor-augmented …
Recent advances in closed-loop insulin delivery.
Ware J, Hovorka R. Ware J, et al. Metabolism. 2022 Feb;127:154953. doi: 10.1016/j.metabol.2021.154953. Epub 2021 Dec 7. Metabolism. 2022. PMID: 34890648 Free PMC article. Review.
Since the discovery of insulin 100 years ago, we have seen considerable advances across diabetes therapies. The more recent advent of glucose-responsive automated insulin delivery has started to revolutionise the management of type 1 diabetes in childr …
Since the discovery of insulin 100 years ago, we have seen considerable advances across diabetes therapies. The more recent advent of …
Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions.
Templer S. Templer S. Front Endocrinol (Lausanne). 2022 Jun 6;13:919942. doi: 10.3389/fendo.2022.919942. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35733769 Free PMC article. Review.
Closed-loop (artificial pancreas) systems for automated insulin delivery have been likened to the holy grail of diabetes management. ...As the number of commercially available hybrid closed-loop systems has grown, so too has the ev …
Closed-loop (artificial pancreas) systems for automated insulin delivery have been likened to the holy gr …
Practical implementation of automated closed-loop insulin delivery: A French position statement.
Tubiana-Rufi N, Schaepelynck P, Franc S, Chaillous L, Joubert M, Renard E, Reznik Y, Abettan C, Bismuth E, Beltrand J, Bonnemaison E, Borot S, Charpentier G, Delemer B, Desserprix A, Durain D, Farret A, Filhol N, Guerci B, Guilhem I, Guillot C, Jeandidier N, Lablanche S, Leroy R, Melki V, Munch M, Penfornis A, Picard S, Place J, Riveline JP, Serusclat P, Sola-Gazagnes A, Thivolet C, Hanaire H, Benhamou PY; SFD SFD Paramedical SFE SFEDP AJD FFD FENAREDIAM and CNP-EDN. Tubiana-Rufi N, et al. Diabetes Metab. 2021 May;47(3):101206. doi: 10.1016/j.diabet.2020.10.004. Epub 2020 Nov 2. Diabetes Metab. 2021. PMID: 33152550
Automated closed-loop (CL) insulin therapy has come of age. This major technological advance is expected to significantly improve the quality of care for adults, adolescents and children with type 1 diabetes. ...
Automated closed-loop (CL) insulin therapy has come of age. This major technological advance is expected to sign …
Does fully closed-loop automated insulin delivery improve glycaemic control in patients with type 2 diabetes? A meta-analysis of randomized controlled trials.
Amer BE, Yaqout YE, Abozaid AM, Afifi E, Aboelkhier MM. Amer BE, et al. Diabet Med. 2024 Jan;41(1):e15196. doi: 10.1111/dme.15196. Epub 2023 Aug 18. Diabet Med. 2024. PMID: 37567739
AIMS: This meta-analysis investigated the efficacy and safety of fully closed-loop automated insulin delivery (AID) in patients with type 2 diabetes. MATERIALS AND METHODS: We systemically searched PubMed, Scopus, Web of Science, and Cochrane Ce …
AIMS: This meta-analysis investigated the efficacy and safety of fully closed-loop automated insulin delivery …
The Artificial Pancreas and Type 1 Diabetes.
Nwokolo M, Hovorka R. Nwokolo M, et al. J Clin Endocrinol Metab. 2023 Jun 16;108(7):1614-1623. doi: 10.1210/clinem/dgad068. J Clin Endocrinol Metab. 2023. PMID: 36734145 Free PMC article. Review.
Automating insulin delivery reduces the input required from those wearing the device, leading to better physiological and psychosocial outcomes. Hybrid closed-loop therapy systems, requiring user-initiated prandial insulin doses, are the …
Automating insulin delivery reduces the input required from those wearing the device, leading to better physiological a …
645 results